Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-peptide vaccine (URLC10, KOC1, VEGFR1, VEGFR2) in refractory gastric cancer
NCT00681577Phase 2Completed
- Sponsor
- The University of Tokyo
- Start
- May 2008
- Primary completion
- Oct 2009
- Modality
- Peptide-based Cancer Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of URLC10 in gastric cancer (GC), sponsored by The University of Tokyo. Started May 2008; status: completed.
02
Drugs
URLC10
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00681577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00681577.